Evaluation of CEST MR-Iimaging to classify sarcomas and to predict their course of therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022758

Enrollment

Registered

2020-08-03

Start date

2020-08-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49.9 C41.9

Interventions

Group 1: CEST-MRI

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: suspicion of sarcoma

Exclusion criteria

Exclusion criteria: - General exclusion criteria for magnetic resonance imaging - pregnancy - childern

Design outcomes

Primary

Measure	Time frame
Exclusion of tumor recurrence	—

Secondary

Measure	Time frame
relapse-free survival	—

Countries

Germany

Contacts

Public ContactJohannes Roßkopf

Klinik für diagnostische und interventionelle Radiologie der Universitätsklinik Ulm

johannes.rosskopf@uni-ulm.de073150061111

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026